- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01418508
Effects of Low Protein Diet Supplemented Keto-/Amino Acid in Preventing the Progression of Chronic Kidney Disease (CKD)- ELPD Study (ELPD-CKD)
Effects of Low Protein Diet Supplemented Keto-/Amino Acid in Preventing the Progression of Chronic Kidney Disease(CKD)- ELPD Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Dietary protein restriction represents a basic therapeutic approach in chronic kidney disease(CKD), by reducing the accumulation of nitrogen catabolic substances, and by delaying the progress of CKD and proteinuria, but the effects of the different degree's protein diet on the renal progression remain to be determined.
The aim of this study is to evaluate the efficacy of low protein diet and α-keto acid tablet in retard the progress of CKD. This is a randomized, open-label, prospective study, 120 patients who meet inclusion and exclusion criteria will be randomized into three groups at the ratio of 1:1:1. Group I patients will receive low protein diet(0.6g/kg BW), group II will receive low protein diet supplemented with α-keto acid, while group III will take very low protein diet(0.3g/kg BW) supplemented with α-keto acid. The changes of glomerular filtration rate in CKD will be evaluated after 1 year treatment.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Xuemei Li, M.D.& Ph.D.
- Phone Number: 8610-65295058
- Email: 0605.mei@gmail.com
Study Contact Backup
- Name: Limeng Chen, M.D.& Ph.D.
- Phone Number: 8610-65295351
- Email: climeng2000@yahoo.com.cn
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100730
- Recruiting
- Peking Union Medical College Hospital
-
Contact:
- Xuemei Li, M.D.& Ph.D.
- Phone Number: 8610-65295058
- Email: 0605.mei@gmail.com
-
Contact:
- Limeng Chen, M.D.& Ph.D.
- Phone Number: 8610-65295351
- Email: climeng2000@yahoo.com.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with chronic kidney disease in stage 3b and 4(15ml/min/1.73m2<GFR<45 ml/min/1.73m2, estimated by EPI formula) receiving conservative treatment for CKD
Exclusion Criteria:
- With diagnosis of diabetic mellitus;
- Incapable of following study requirements to control diet;
- Glomerular filtration rate < 15 ml/min/1.73m2;
- Hypercalcemia or hyperkalemia (> normal upper limit);
- Other serious disease(eg.heart,lung,brain) within the last 3 months;
- Cardiac failure stage IV NYHA;
- With cirrhosis of liver or obvious symptoms of liver diseases, ALT or AST two times normal upper limit;
- Severe edema or serous cavity effusion;
- Drug abuse;
- Final diagnosis of malignant tumor;
- Receiving the long-term systematic steroid hormone or immunosuppressive agents(eg. Cyclophosphamidum,Cyclosporine, Prograf,Azathioprine) treatment;
- Gestation already, prepares to be pregnant in the period of the trial, lactating women;
- Participate in other product clinical trial within 30 days prior to this trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: low protein diet
Behavioral: low protein diet 0.6g of proteins per kilo of body weight per day
|
|
Experimental: low protein diet plusα-keto acid
0.6g of proteins per kilo of body weight per day
|
low protein diet plus α-keto acid 0.6g of proteins per kilo of body weight per day, supplemented with α-keto acid tablets
|
Experimental: very low protein diet plus α-keto acid
0.3g of proteins per kilo of body weight per day
|
very low protein diet plus α-keto acid 0.3g of proteins per kilo of body weight per day, supplemented with α-keto acid tablets
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
changes in glomerular filtration rate
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compliance to diet
Time Frame: 1 year
|
1 year
|
|
Quality of life
Time Frame: 1 year
|
1 year
|
|
Cardiovascular morbidity
Time Frame: 1 year
|
Cardiovascular morbidity, defined by angina, heart failure, myocardial infarction, left ventricular mass, stroke, blood pressure, lipid profile, calcium/phosphorus/parathormone status and Charlson comorbidity index, at the start of dialysis
|
1 year
|
Nutritional status
Time Frame: 1 year
|
Nutritional status, defined by anthropo-plicometry, biochemistry, body bioimpedance analysis (BIA), subjective global nutritional assessment (SGA), at the start and during the 1st year of dialysis
|
1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Xuemei Li, M.D.& Ph.D., Peking Union Medical College Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ELPD-CKD
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Lund UniversityBaxter Healthcare Corporation; Universidad de CórdobaCompletedEnd Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisArgentina
-
Centre Hospitalier Saint Joseph Saint Luc de LyonNot yet recruitingKidney Failure, Chronic | Diet Habit | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 3B | Chronic Kidney Disease, Stage 3 (Moderate) | Chronic Kidney Disease Stage 3A (Disorder)France
-
A.C. AbrahamsCompletedEnd Stage Renal Disease | Chronic Kidney Disease | End Stage Kidney Disease | Chronic Kidney FailureNetherlands
-
Far Eastern Memorial HospitalActive, not recruitingMetabolic Syndrome | Chronic Disease | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease Stage 3 | Chronic Kidney Disease Stage 4 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
Clinical Trials on low protein diet plus α-keto acid
-
The Third Xiangya Hospital of Central South UniversityUnknownRenal Insufficiency, ChronicChina
-
Sun Yat-sen UniversityCompleted
-
Sun Yat-sen UniversityBeijing Fresenius Kabi Pharmaceutical CoCompletedRenal Function DisorderChina
-
Anemia Working Group RomaniaDr Carol Davila Teaching Hospital of Nephrology BucharestCompletedChronic Kidney DiseaseRomania
-
Alexandria UniversityRecruitingChronic Kidney DiseasesEgypt
-
Peking University First HospitalVanderbilt UniversityCompletedInsulin ResistanceChina
-
University Psychiatric Clinics BaselNot yet recruitingDepressive Disorder | Major Depressive Disorder | Depression, Bipolar
-
Ohio State University Comprehensive Cancer CenterBreast Cancer Research FoundationCompletedBreast Cancer | Weight LossUnited States
-
Azienda Sanitaria ASL Avellino 2UnknownChronic Renal InsufficiencyItaly
-
University of BonnFederal Ministry of Food and Agriculture (BMEL); Federal Office for Agriculture...RecruitingCardiovascular Diseases | Metabolic SyndromeGermany